Details of the Drug Reposition

General Information of This Drug (ID: DMY6V5T)

Drug Name
ICasp9M28z T cell   DMY6V5T
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Lung cancer DISCM4YA 2C25.0 Phase 1 [1]
Mesothelioma DISKWK9M 2C51.2 Phase 1 [1]
Metastatic malignant neoplasm DIS86UK6 2D50-2E09 Phase 1 [1]
Malignant pleural effusion DISVEVSJ 2D72 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02414269) Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin